Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study: Sequential Administration of Allogeneic Mesenchymal Stem Cells Thawed or Expanded in Vitro for the Treatment of Acute Graft-versus-host Disease Refractory to Second Line Treatment

NCT06304025 is registered in ClinicalTrials.gov with Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle as lead sponsor.

NCT NCT06304025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06304025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study: Sequential Administration of Allogeneic Mesenchymal Stem Cells Thawed or Expanded in Vitro for the Treatment of Acute Graft-versus-host Disease Refractory to Second Line Treatment
Lead sponsor
Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle
Phase
Phase 1/2
Overall status
Unknown status
Start date
June 30, 2024
Completion date
August 31, 2025
Enrollment
10 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

graft versus host disease